Annual Growth in Roche's Sequencing Business Fueled by GS Junior Sales; New Products Planned for 2011

Roche realized a 17 percent revenue increase in its sequencing and array business last year, driven largely by sales of its GS Junior, the company reported last week.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.